I have never been to Brazil's "beautiful horizon", Belo Horizonte, the country's third-largest metropolitan area and an information and bio-technology hub, but I have followed the city's progress against what was once its enduring shame: hunger. In 1993, when 11% of its 2.5 million people lived in absolute poverty and a fifth of Belo's children went hungry, a newly-elected government declared that food was a fundamental right of every citizen,...

-The Times of India   As consumers open up to digital products, their personal data is being valued more and more as an asset. Facebook's looming $100 billion valuation is based on a presumption of having personal information on millions of users, which can be used to target advertising and content towards them. And Google is moving to collect similar information. Globally, the power of data aggregators is raising serious concerns around...

The Centre is keen to resolve differences with rights activists over the remuneration under its flagship rural job guarantee scheme, which can potentially save it from paying 7,000 crore in arrears to states that have higher minimum wages.  Wages under the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS) have risen for all states after the government made adjustments for price rise last month. But despite the revision, the payout is...

One man’s fiscal problem is another man’s lifeline. Trigger happy bureaucrats and economists may love shooting down subsidies because it bloats the fiscal deficit and burdens the government but the simple fact is that in a one billion strong nation, in which nearly one in every three live below the poverty line, one needs an effective and efficient method through which privileged tax payers can support the poor. Last week, finance...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...